Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | e7-e11 |
Tijdschrift | British Journal of Haematology |
Volume | 186 |
Nummer van het tijdschrift | 3 |
DOI's | |
Status | Gepubliceerd - aug. 2019 |
Extern gepubliceerd | Ja |
Toegang tot document
Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: British Journal of Haematology, Vol. 186, Nr. 3, 08.2019, blz. e7-e11.
Onderzoeksoutput: Bijdrage aan tijdschrift › Brief › peer review
TY - JOUR
T1 - Phase 1–2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia
AU - Kearns, Pamela
AU - Zwaan, Christian M.
AU - Reinhardt, Dirk
AU - Gibson, Brenda
AU - Moreno, Lucas
AU - Nysom, Karsten
AU - Nakahara, Susumu
AU - Huang, Fei
AU - Zhou, Wangda
AU - Parasrampuria, Dolly A.
AU - Nemat, Sepideh
N1 - Funding Information: This work was funded by Janssen Research & Development, LLC. The sponsor was involved in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. Funding Information: Dr. Kearns has consulted for Genzyme, Janssen, Bristol-Myers Squibb, Bayer and AbbVie. Dr. Zwaan has received grants and consulted for Pfizer, received travel grants from Jazz, speakers fee for Novartis and consulted for Sanofi. Dr. Reinhardt has provided paid expert testimony for Blue Bird Bio, Novartis, Boehringer and Roche, and received grants from Celgene and CSL Behring. Dr. Moreno has participated in advisory boards for Novartis, AstraZeneca, Roche/Genentech, Mundipharma, Bayer and Amgen, and received honoraria from Celgene for an educational event and travel grants from Celgene and Amgen. Dr. Nysom has participated in advisory boards for Bayer. Drs. Nakahara, Huang, Zhou, Parasrampuria, and Nemat are employees of Janssen R&D and own Johnson & Johnson stock. Dr. Gibson reports no declarations of interest. Medical writing assistance was provided by Tracy T. Cao, PhD of Janssen Global Services, LLC and was funded by Janssen Global Services, LLC.
PY - 2019/8
Y1 - 2019/8
KW - acute myeloid leukaemia
KW - CDKN2B
KW - cytarabine
KW - decitabine
KW - DNA methylation
KW - ESR1
UR - http://www.scopus.com/inward/record.url?scp=85062693641&partnerID=8YFLogxK
U2 - 10.1111/bjh.15847
DO - 10.1111/bjh.15847
M3 - Letter
C2 - 30847896
AN - SCOPUS:85062693641
SN - 0007-1048
VL - 186
SP - e7-e11
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 3
ER -